Real-time image-guided direct convective perfusion of intrinsic brainstem lesions: Technical note

Journal of Neurosurgery

Volumn 107, Issue 1, 2007, Pages 190-197

  Lonser, Russell R ^a   Warren, Katherine E ^b   Butman, John A ^c   Quezado, Zenaide ^c   Robison, R Aaron ^a   Walbridge, Stuart ^a   Schiffman, Raphael ^a   Merrill, Marsha ^a   Walker, Marion L ^d   Park, Deric M ^a   Croteau, David ^e   Brady, Roscoe O ^a   Oldfield, Edward H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^e NeoPharm Inc   (United States)

Author keywords

Brainstem; Convection enhanced delivery; Glioma; Intraoperative imaging; Magnetic resonance imaging

Indexed keywords

GLUCOSYLCERAMIDASE; INTERLEUKIN 13; PENTETIC ACID; TEMOZOLOMIDE;

ARTICLE; BONE MARROW BIOPSY; BRAIN STEM; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; ELECTROCORTICOGRAPHY; FEEDING APPARATUS; FEMALE; GAUCHER DISEASE; GLIOMA; HUMAN; HYDROCEPHALUS; INFANT; INTERMITTENT STRABISMUS; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; TRACHEOSTOMY; TUMOR GROWTH;

BRAIN STEM; CATHETERS, INDWELLING; CEREBELLAR NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FACIAL PARALYSIS; GADOLINIUM DTPA; GAUCHER DISEASE; GLIOMA; HUMANS; INFANT, NEWBORN; INTRAOPERATIVE CARE; MAGNETIC RESONANCE IMAGING; MALE; NEUROSURGICAL PROCEDURES; PERFUSION; PONS; SURGERY, COMPUTER-ASSISTED;

EID: 34347374678     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/JNS-07/07/0190     Document Type: Article

References (37)

1. Altarescu G, Hill S, Wiggs E, Jeffries N, Kreps C, Parker CC, et al: The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease. J Pediatr 138:539-547, 2001
2. Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, et al: Replacement therapy for inherited enzyme deficiency - macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 324:1464-1470, 1991
3. Blasberg RG, Patlak C, Fenstermacher JD: Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther 195:73-83, 1975
4. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91:2076-2080, 1994
5. Brady RO: Glucosyl ceremide lipidosis: Gaucher's disease, in Stanbury JB, Wyngaarden JB, Frederickson DS (eds): The Metabolic Basis of Inherited Disease, ed 4. New York: McGraw-Hill, 1978, pp 731-746
6. Brady RO: Therapy for the sphingolipidoses. Arch Neurol 55:1055-1056, 1998
7. Brady RO, Pentchev PG, Gal AE, Hibbert SR, Dekaban AS: Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease. N Engl J Med 291:989-993, 1974
8. Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH: Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 90:315-320, 1999
9. Croteau D, Walbridge S, Morrison PF, Butman JA, Vortmeyer AO, Johnson D, et al: Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg 102:90-97, 2005
10. Debinski W, Obiri NI, Powers SK, Pastan I, Puri RK: Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. Clin Cancer Res 1:1253-1258, 1995
11. Donaldson SS, Laningham F, Fisher PG: Advances toward an understanding of brainstem gliomas. J Clin Oncol 24:1266-1272, 2006
12. Hargrave D, Bartels U, Bouffet E: Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241-248, 2006
13. Hood TW, Gebarski SS, McKeever PE, Venes JL: Stereotaxic biopsy of intrinsic lesions of the brain stem. J Neurosurg 65:172-176, 1986
14. Husain SR, Joshi BH, Puri RK: Interleukin-13 receptor as a unique target for anti-glioblastoma therapy. Int J Cancer 92:168-175, 2001
15. Joshi BH, Husain SR, Puri RK: Preclinical studies with IL-13PE38QQR for therapy of malignant glioma. Drug News Perspect 13:599-605, 2000
16. Kawakami K, Kawakami M, Puri RK: IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancer. J Immunol 169:7119-7126, 2002
17. Kawakami M, Kawakami K, Puri RK: Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts. Mol Cancer Ther 1:999-1007, 2002
18. Kawakami M, Leland P, Kawakami K, Puri RK: Mutation and functional analysis of IL-13 receptors in human malignant glioma cells. Oncol Res 12:459-467, 2000
19. Kunwar S: Convection enhanced delivery of IL13-pE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies. Acta Neurochir Suppl 88:105-111, 2003
20. Langer R: New methods of drug delivery. Science 249:1527-1533, 1990
21. Laske DW, Morrison PF, Lieberman DM, Corthesy ME, Reynolds JC, Stewart-Henney PA, et al: Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg 87:586-594, 1997
22. Laske DW, Youle RJ, Oldfield EH: Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3:1362-1368, 1997
23. Lieberman DM, Laske DW, Morrison PF, Bankiewicz KS, Oldfield EH: Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg 82:1021-1029, 1995
24. Lonser RR, Gogate N, Morrison PF, Wood JD, Oldfield EH: Direct convective delivery of macromolecules to the spinal cord. J Neurosurg 89:616-622, 1998
25. Lonser RR, Schiffmann R, Robison RA, Butman JA, Quezado Z, Walker ML, et al: Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology 68:254-261, 2007
26. Lonser RR, Walbridge S, Garmestani K, Butman JA, Walters HA, Vortmeyer AO, et al: Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg 97:905-913, 2002
27. Mardor Y, Roth Y, Ochershvilli A, Spiegelmann R, Tichler T, Daniels D, et al: Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 6:136-142, 2004
28. Mignot C, Doummar D, Maire I, De Villemeur TB: Type 2 Gaucher disease: 15 new cases and review of the literature. Brain Dev 28:39-48, 2006
29. Morrison P: Distribution models of drug kinetics, in Atkinson AJ Jr, Daniels CE, Dedrick R, Grudzinskas CV, Markey SP (eds): Principles of Clinical Pharmacology. New York: Academic Press, 2001, pp 93-112
30. Morrison PF, Chen MY, Chadwick RS, Lonser RR, Oldfield EH: Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. Am J Physiol 277:R1218-R1229, 1999
31. Murad GJA, Walbridge S, Morrison PF, Garmestani K, Degen JW, Brechbiel MW, et al: Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res 12:3145-3151, 2006
32. Pardridge WM: Drug delivery to the brain. J Cereb Blood Flow Metab 17:713-731, 1997
33. Patel SJ, Shapiro WR, Laske DW, Jensen RL, Asher AL, Wessels BW, et al: Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery 56:1243-1253, 2005
34. Sampson JH, Akabani G, Friedman AH, Bigner D, Kunwar S, Berger MS, et al: Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies. Neurosurg Focus 20(4):E14, 2006
35. Verity MA, Montasir M: Infantile Gaucher's disease: neuropathology, acid hydrolase activities and negative staining observations. Neuropadiatrie 8:89-100, 1977
36. Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, et al: Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med 113:112-119, 2002
37. Wood JD, Lonser RR, Gogate N, Morrison PF, Oldfield EH: Convective delivery of macromolecules into the naive and traumatized spinal cords of rats. J Neurosurg 90 (1 Suppl):115-120, 1999